agilon health inc
NYSE:AGL
Relative Value
The Relative Value of one AGL stock under the Base Case scenario is 48.46 USD. Compared to the current market price of 5.38 USD, agilon health inc is Undervalued by 89%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
AGL Competitors Multiples
agilon health inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
agilon health inc
NYSE:AGL
|
2.2B USD | 0.5 | -8.3 | -8.2 | -7.5 | ||
US |
Cigna Corp
NYSE:CI
|
102B USD | 0.5 | 19.8 | 10.2 | 13.6 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
95.5B EUR | 0.5 | 19.7 | 10.1 | 13.5 | |
US |
CVS Health Corp
NYSE:CVS
|
89.4B USD | 0.2 | 10.7 | 9.1 | 9.1 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
20.8B EUR | 1.1 | 41.8 | 9.9 | 23.6 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.7B USD | 1.4 | 40 | 12 | 18.1 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15B EUR | 0.7 | -25.3 | 9.8 | 22 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
14B USD | 1.5 | 16.4 | 10.1 | 13.4 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.7B EUR | 0.5 | 21.4 | 6.6 | 15.6 | |
US |
DaVita Inc
NYSE:DVA
|
11.2B USD | 0.9 | 16.2 | 8.1 | 11.9 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |